Siena Biotech is a privately held biotechnology company operating in the biomedical field of oncology and neurodenerative diseases, including rare diseases. The company was founded by its major shareholder Monte dei Paschi di Siena Foundation as operational company to perform in the field of pharmaceutical research and biotechnology.

The Monte dei Paschi di Siena Foundation is a non-profit organization operating totally within the sphere of private law which pursues aims of social utility through the management of its assets, derived primarily from its major stake in Monte dei Paschi di Siena Bank.

The primary goal of Monte dei Paschi di Siena Foundation is to evolve and develop the economies of the territory of Siena, impacting the community with the aim of improving quality of life. Siena Biotech is an operational arm of Monte dei Paschi di Siena Foundation to achieve its objectives.

For more information, visit Fondazione Monte dei Paschi website